Navigation Links
SemBioSys' GLA Partner Enters Strategic Alliance for the Sales and Marketing of GLA-Rich Safflower Oil
Date:3/14/2008

TSX symbol: SBS

CALGARY, March 14 /PRNewswire-FirstCall/ - SemBioSys Genetics Inc. (TSX: SBS), a biotechnology company developing a portfolio of therapeutic proteins for metabolic and cardiovascular diseases, today announced that Arcadia Biosciences, Inc., made an important step forward in the commercialization of High GLA Safflower Oil. Arcadia entered into an exclusive global alliance with Bioriginal Food and Science Corp., to market and distribute High GLA Safflower Oil, an omega-6 polyunsaturated fatty acid with proven heath benefits, as a nutritional supplement and food ingredient. SemBioSys was contracted by Arcadia to utilize Arcadia's proprietary genes and SemBioSys' promoters and safflower transformation technology to produce and deliver safflower seed lines containing more than 40 percent GLA. Under the agreement, SemBioSys receives milestone payments upon the successful scale-up of GLA safflower lines as well as royalties from commercial sales.

GLA (gamma linolenic acid) is an omega-6 polyunsaturated fatty acid which, along with omega-3 fatty acids, has demonstrated health benefits. GLA's clinically-validated benefits include anti-inflammatory effects and improved skin health and appearance. Existing commercial sources of GLA, evening primrose oil and borage oil, contain 10 or 20-23 percent GLA, respectively. With a GLA content of 40 percent, Arcadia's high-GLA safflower oil would significantly reduce the daily consumption of GLA oil capsules and make it more convenient and affordable for consumers. According to ICIS Chemical Business Americas, the U.S. market for GLA oils is currently valued at more than US$100 million. With a more convenient, more highly concentrated source of GLA, Arcadia believes the market can grow beyond this figure.

"Nutritional supplements and nutraceuticals are a growing market as health conscious consumers are increasingly choosing to augment their diet with nutrients that ha
'/>"/>

SOURCE SemBioSys Genetics Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. SemBioSys updates Apo AI development program
2. SemBioSys to present insulin data at the Seventh Annual Diabetes Technology Meeting
3. SemBioSys announces 2007 third quarter results
4. SemBioSys signs option agreement for safflower-produced food ingredient
5. SemBioSys to present at the 10th Annual BIO CEO & Investor Conference
6. SemBioSys awarded key patent for the production of oleosome emulsions by the European Patent Office
7. ONCOSCIENCE AG, THE EUROPEAN PARTNER OF YM BIOSCIENCES, ANNOUNCES COMPLETION OF PATIENT ENROLLMENT IN PHASE III BRAIN CANCER TRIAL OF NIMOTUZUMAB
8. YM BIOSCIENCES, EUROPEAN PARTNER, ONCOSCIENCE AG, ANNOUNCES INITIATION OF ADVANCED NIMOTUZUMAB TRIALS IN ADULT GLIOMA AND PANCREATIC CANCER
9. Operon Biotechnologies and DNA2.0 Announce Co-Marketing and Technology Development Partnership
10. NuVasive to Present at Thomas Weisel Partners Healthcare Conference
11. Monogram Biosciences to Present at the Thomas Weisel Partners Healthcare Conference 2007

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/5/2009)...PRNewswire/ -- DSM Pharmaceutical Products today a... with Galenix, Saint Jean D,Illac, France, where D...uring partner for Galenix commercial products on a...ate on business development opportunities co-marke...the strength of Galenix in drug product developmen...
(Date:11/5/2009)...Newswire-FirstCall/ -- BioSpecifics Technologies C... developing first-in-class collagenase-based produ... third quarter ended September 30, 2009. ,, "W...year, the FDA,s Arthritis Advisory Committee unani...l of XIAFLEX(TM) for the treatment of Dupuytren,s ...
(Date:11/5/2009)...ewswire/ -- SpineSmith Partners has signed an init...unique scaffold that mimics the structure of natur...al commercial products by SpineSmith,s Research an... GenOsteo scaffold represents a significant advanc...l environment for the delivery of adult stem cells...
(Date:11/4/2009)...ebinar, which will be presented on November 19 and...ow chemistry processing, will deal with the applic...s meso and micro scale flow chemistry equipment. ...been recognized with several prestigious prizes an...dron Prize. , Columbia, M...
Breaking Biology Technology:DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 2DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 3BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 2BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 3BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 4BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 5SpineSmith Partners and GenOsteo Announce Collaborative Product Development Agreement 2Professor Steven Ley of University of Cambridge will Present Free Webinar, 'Application of the ReactIR Flow Cell to Continuous Processing Technology' 2Professor Steven Ley of University of Cambridge will Present Free Webinar, 'Application of the ReactIR Flow Cell to Continuous Processing Technology' 3
...ation,(Nasdaq: CRGN ), a clinical-stage biopharma...ced that it received a letter, dated January 28,20...n that during the,preceding 30 consecutive trading...tock has been below the $1.00 minimum bid per shar...bal Market under NASDAQ Marketplace Rule,4450(a)(5...
...cientific Inc. (NYSE: TMO ), the world leader in ... the 2008 Merrill Lynch Global Pharmaceutical,Biot...t the Grand Hyatt,Hotel in New York City. The comp...9:20 am (EST)., Marijn E. Dekkers, president and ...c, will provide an overview of the company and dis...
...iences, Inc. (Nasdaq: SGMO ) today announced that...ear-end 2007 financial results on Tuesday,February...se will be,followed by a conference call at 2:00 p...hone and webcast. During the conference call, the ...uss other business matters., The conference call ...
Other Biology Technology:CuraGen Corporation Receives Notification from NASDAQ 2CuraGen Corporation Receives Notification from NASDAQ 3Thermo Fisher Scientific to Present at the 2008 Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference 2Sangamo BioSciences Announces Fourth Quarter and Year-End 2007 Conference Call and Webcast 2Sangamo BioSciences Announces Fourth Quarter and Year-End 2007 Conference Call and Webcast 3
(Date:11/4/2009)...-FirstCall/ -- BIO-key International, Inc. (OTC Bu...etric identification software is showcasing donor ...nference being held at the New Orleans Convention ...de hands-on product demonstrations of its state-of...Also, at 5 PM on Monday, October 26, Peter Lux, ma...
(Date:11/4/2009)... Glencoe Software, Inc., the commercial arm of the...ttp://openmicroscopy.org ), is proud to announce ...l Biology,s exciting new project titled "The Cell:....5M stimulus grant through the National Institutes... part of the American Reinvestment and Recovery Ac...
(Date:11/3/2009)...rt published in a recent issue of HortTechnology ...ed the effects of covering orchard floors with ref...y light distribution, orchard temperature, and pro...xtenday and Solarmate films installed 5 weeks befo..., apples. The research showed that the use of both...
Breaking Biology News(10 mins):BIO-key(R) International Exhibiting at AABB TXPO 2Glencoe Software to Support the ASCB 'Stimulus Grant' to Build Virtual Image Library of the Cell 2Reflective film can boost profits for apple growers 2Cepheid Reports 2009 Second Quarter Results 53277 1Cepheid Reports 2009 Second Quarter Results 53277 2Cepheid Reports 2009 Second Quarter Results 53277 3Cepheid Reports 2009 Second Quarter Results 53277 4Cepheid Reports 2009 Second Quarter Results 53277 5Cepheid Reports 2009 Second Quarter Results 53277 6Cepheid Reports 2009 Second Quarter Results 53277 7Cepheid Reports 2009 Second Quarter Results 53277 8Cepheid Reports 2009 Second Quarter Results 53277 9Cepheid Reports 2009 Second Quarter Results 53277 10Cepheid Reports 2009 Second Quarter Results 53277 11Cepheid Reports 2009 Second Quarter Results 53277 12Cepheid Reports 2009 Second Quarter Results 53277 13Cepheid Reports 2009 Second Quarter Results 53277 14Cepheid Reports 2009 Second Quarter Results 53277 15Cepheid Reports 2009 Second Quarter Results 53277 16Cepheid Reports 2009 Second Quarter Results 53277 17Cepheid Reports 2009 Second Quarter Results 53277 18Trubion Announces Dates for Second Quarter and First Half 2009 Earnings Conference Call 13296 1Trubion Announces Dates for Second Quarter and First Half 2009 Earnings Conference Call 13296 2Flu Shot May Be Less Effective in Those With Lupus 53274 1Flu Shot May Be Less Effective in Those With Lupus 53274 2
...lease is also available in Spanish . , Barcelo... number of times women undergo assisted reproducti...the overwhelming majority achieve a pregnancy with...age of 40 had a more consistent, but lower, pregna...attempts. , Mr Simon Hong told the 24th annual m...
...e current drive towards production of alternative ... down this material into useable compounds are req... One group of scientists from Texas A&M University...e the enzymes. Professor Zivko Nikolov, who leads...rch on Monday 7th July at the Society for Experime...
...STATION, July 7, 2008 A study published in the cu...belief that diversity of marine species has been i.... Dr. Thomas D. Olszewski, a geology and geophysic...rt of the international team that carried out this...he diversification occurred early on relatively s...
Other Biology News:Failure of the 1st attempt at assisted reproduction justifies at least 1 additional cycle 2Failure of the 1st attempt at assisted reproduction justifies at least 1 additional cycle 3A green solution to biofuel production 2Setting the record right: species diversity less dramatic than previously believed 2
BLOCK-iT siRNA, Stealth and Custom RNA from Invitrogen
...atoms at the 9, 10, 12, and 13 positions. It is in...ntification of 13(S)-HODE by GC- or LC-mass spectr...noleic acid with plant and mammalian lipoxygenases...or cells to the endothelium at concentrations arou...
Adaptor BamH I-Sma I from Takara Mirus Bio
Cassette, Hind III from Takara Mirus Bio
Biology Products: